HPLN1 Antibody Market - Global Outlook and Forecast 2022-2028

January 2022 | 73 pages | ID: H423B1327490EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of HPLN1 Antibody in Global, including the following market information:

Global HPLN1 Antibody Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global HPLN1 Antibody market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Above 90% Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of HPLN1 Antibody include Thermo Fisher Scientific, R&D Systems, Novus Biologicals, Abcam, Lifespan Biosciences, Boster Bio, Santa Cruz Biotechnology, RayBiotech and Abbexa Ltd, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the HPLN1 Antibody companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global HPLN1 Antibody Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global HPLN1 Antibody Market Segment Percentages, by Type, 2021 (%)

• Above 90%
• Above 95%
• Above 99%
• Others

Global HPLN1 Antibody Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global HPLN1 Antibody Market Segment Percentages, by Application, 2021 (%)

• Biopharmaceutical Companies
• Hospitals
• Bioscience Research Institutions
• Others

Global HPLN1 Antibody Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global HPLN1 Antibody Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies HPLN1 Antibody revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies HPLN1 Antibody revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Thermo Fisher Scientific
• R&D Systems
• Novus Biologicals
• Abcam
• Lifespan Biosciences
• Boster Bio
• Santa Cruz Biotechnology
• RayBiotech
• Abbexa Ltd
• Genetex
• Biobyt
• Aviva Systems Biology

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 HPLN1 Antibody Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global HPLN1 Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HPLN1 ANTIBODY OVERALL MARKET SIZE

2.1 Global HPLN1 Antibody Market Size: 2021 VS 2028
2.2 Global HPLN1 Antibody Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top HPLN1 Antibody Players in Global Market
3.2 Top Global HPLN1 Antibody Companies Ranked by Revenue
3.3 Global HPLN1 Antibody Revenue by Companies
3.4 Top 3 and Top 5 HPLN1 Antibody Companies in Global Market, by Revenue in 2021
3.5 Global Companies HPLN1 Antibody Product Type
3.6 Tier 1, Tier 2 and Tier 3 HPLN1 Antibody Players in Global Market
  3.6.1 List of Global Tier 1 HPLN1 Antibody Companies
  3.6.2 List of Global Tier 2 and Tier 3 HPLN1 Antibody Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global HPLN1 Antibody Market Size Markets, 2021 & 2028
  4.1.2 Above 90%
  4.1.3 Above 95%
  4.1.4 Above 99%
  4.1.5 Others
4.2 By Type - Global HPLN1 Antibody Revenue & Forecasts
  4.2.1 By Type - Global HPLN1 Antibody Revenue, 2017-2022
  4.2.2 By Type - Global HPLN1 Antibody Revenue, 2023-2028
  4.2.3 By Type - Global HPLN1 Antibody Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global HPLN1 Antibody Market Size, 2021 & 2028
  5.1.2 Biopharmaceutical Companies
  5.1.3 Hospitals
  5.1.4 Bioscience Research Institutions
  5.1.5 Others
5.2 By Application - Global HPLN1 Antibody Revenue & Forecasts
  5.2.1 By Application - Global HPLN1 Antibody Revenue, 2017-2022
  5.2.2 By Application - Global HPLN1 Antibody Revenue, 2023-2028
  5.2.3 By Application - Global HPLN1 Antibody Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global HPLN1 Antibody Market Size, 2021 & 2028
6.2 By Region - Global HPLN1 Antibody Revenue & Forecasts
  6.2.1 By Region - Global HPLN1 Antibody Revenue, 2017-2022
  6.2.2 By Region - Global HPLN1 Antibody Revenue, 2023-2028
  6.2.3 By Region - Global HPLN1 Antibody Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America HPLN1 Antibody Revenue, 2017-2028
  6.3.2 US HPLN1 Antibody Market Size, 2017-2028
  6.3.3 Canada HPLN1 Antibody Market Size, 2017-2028
  6.3.4 Mexico HPLN1 Antibody Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe HPLN1 Antibody Revenue, 2017-2028
  6.4.2 Germany HPLN1 Antibody Market Size, 2017-2028
  6.4.3 France HPLN1 Antibody Market Size, 2017-2028
  6.4.4 U.K. HPLN1 Antibody Market Size, 2017-2028
  6.4.5 Italy HPLN1 Antibody Market Size, 2017-2028
  6.4.6 Russia HPLN1 Antibody Market Size, 2017-2028
  6.4.7 Nordic Countries HPLN1 Antibody Market Size, 2017-2028
  6.4.8 Benelux HPLN1 Antibody Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia HPLN1 Antibody Revenue, 2017-2028
  6.5.2 China HPLN1 Antibody Market Size, 2017-2028
  6.5.3 Japan HPLN1 Antibody Market Size, 2017-2028
  6.5.4 South Korea HPLN1 Antibody Market Size, 2017-2028
  6.5.5 Southeast Asia HPLN1 Antibody Market Size, 2017-2028
  6.5.6 India HPLN1 Antibody Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America HPLN1 Antibody Revenue, 2017-2028
  6.6.2 Brazil HPLN1 Antibody Market Size, 2017-2028
  6.6.3 Argentina HPLN1 Antibody Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa HPLN1 Antibody Revenue, 2017-2028
  6.7.2 Turkey HPLN1 Antibody Market Size, 2017-2028
  6.7.3 Israel HPLN1 Antibody Market Size, 2017-2028
  6.7.4 Saudi Arabia HPLN1 Antibody Market Size, 2017-2028
  6.7.5 UAE HPLN1 Antibody Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Thermo Fisher Scientific
  7.1.1 Thermo Fisher Scientific Corporate Summary
  7.1.2 Thermo Fisher Scientific Business Overview
  7.1.3 Thermo Fisher Scientific HPLN1 Antibody Major Product Offerings
  7.1.4 Thermo Fisher Scientific HPLN1 Antibody Revenue in Global Market (2017-2022)
  7.1.5 Thermo Fisher Scientific Key News
7.2 R&D Systems
  7.2.1 R&D Systems Corporate Summary
  7.2.2 R&D Systems Business Overview
  7.2.3 R&D Systems HPLN1 Antibody Major Product Offerings
  7.2.4 R&D Systems HPLN1 Antibody Revenue in Global Market (2017-2022)
  7.2.5 R&D Systems Key News
7.3 Novus Biologicals
  7.3.1 Novus Biologicals Corporate Summary
  7.3.2 Novus Biologicals Business Overview
  7.3.3 Novus Biologicals HPLN1 Antibody Major Product Offerings
  7.3.4 Novus Biologicals HPLN1 Antibody Revenue in Global Market (2017-2022)
  7.3.5 Novus Biologicals Key News
7.4 Abcam
  7.4.1 Abcam Corporate Summary
  7.4.2 Abcam Business Overview
  7.4.3 Abcam HPLN1 Antibody Major Product Offerings
  7.4.4 Abcam HPLN1 Antibody Revenue in Global Market (2017-2022)
  7.4.5 Abcam Key News
7.5 Lifespan Biosciences
  7.5.1 Lifespan Biosciences Corporate Summary
  7.5.2 Lifespan Biosciences Business Overview
  7.5.3 Lifespan Biosciences HPLN1 Antibody Major Product Offerings
  7.5.4 Lifespan Biosciences HPLN1 Antibody Revenue in Global Market (2017-2022)
  7.5.5 Lifespan Biosciences Key News
7.6 Boster Bio
  7.6.1 Boster Bio Corporate Summary
  7.6.2 Boster Bio Business Overview
  7.6.3 Boster Bio HPLN1 Antibody Major Product Offerings
  7.6.4 Boster Bio HPLN1 Antibody Revenue in Global Market (2017-2022)
  7.6.5 Boster Bio Key News
7.7 Santa Cruz Biotechnology
  7.7.1 Santa Cruz Biotechnology Corporate Summary
  7.7.2 Santa Cruz Biotechnology Business Overview
  7.7.3 Santa Cruz Biotechnology HPLN1 Antibody Major Product Offerings
  7.7.4 Santa Cruz Biotechnology HPLN1 Antibody Revenue in Global Market (2017-2022)
  7.7.5 Santa Cruz Biotechnology Key News
7.8 RayBiotech
  7.8.1 RayBiotech Corporate Summary
  7.8.2 RayBiotech Business Overview
  7.8.3 RayBiotech HPLN1 Antibody Major Product Offerings
  7.8.4 RayBiotech HPLN1 Antibody Revenue in Global Market (2017-2022)
  7.8.5 RayBiotech Key News
7.9 Abbexa Ltd
  7.9.1 Abbexa Ltd Corporate Summary
  7.9.2 Abbexa Ltd Business Overview
  7.9.3 Abbexa Ltd HPLN1 Antibody Major Product Offerings
  7.9.4 Abbexa Ltd HPLN1 Antibody Revenue in Global Market (2017-2022)
  7.9.5 Abbexa Ltd Key News
7.10 Genetex
  7.10.1 Genetex Corporate Summary
  7.10.2 Genetex Business Overview
  7.10.3 Genetex HPLN1 Antibody Major Product Offerings
  7.10.4 Genetex HPLN1 Antibody Revenue in Global Market (2017-2022)
  7.10.5 Genetex Key News
7.11 Biobyt
  7.11.1 Biobyt Corporate Summary
  7.11.2 Biobyt Business Overview
  7.11.3 Biobyt HPLN1 Antibody Major Product Offerings
  7.11.4 Biobyt HPLN1 Antibody Revenue in Global Market (2017-2022)
  7.11.5 Biobyt Key News
7.12 Aviva Systems Biology
  7.12.1 Aviva Systems Biology Corporate Summary
  7.12.2 Aviva Systems Biology Business Overview
  7.12.3 Aviva Systems Biology HPLN1 Antibody Major Product Offerings
  7.12.4 Aviva Systems Biology HPLN1 Antibody Revenue in Global Market (2017-2022)
  7.12.5 Aviva Systems Biology Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. HPLN1 Antibody Market Opportunities & Trends in Global Market
Table 2. HPLN1 Antibody Market Drivers in Global Market
Table 3. HPLN1 Antibody Market Restraints in Global Market
Table 4. Key Players of HPLN1 Antibody in Global Market
Table 5. Top HPLN1 Antibody Players in Global Market, Ranking by Revenue (2021)
Table 6. Global HPLN1 Antibody Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global HPLN1 Antibody Revenue Share by Companies, 2017-2022
Table 8. Global Companies HPLN1 Antibody Product Type
Table 9. List of Global Tier 1 HPLN1 Antibody Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 HPLN1 Antibody Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global HPLN1 Antibody Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - HPLN1 Antibody Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - HPLN1 Antibody Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global HPLN1 Antibody Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - HPLN1 Antibody Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - HPLN1 Antibody Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global HPLN1 Antibody Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global HPLN1 Antibody Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global HPLN1 Antibody Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America HPLN1 Antibody Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America HPLN1 Antibody Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe HPLN1 Antibody Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe HPLN1 Antibody Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia HPLN1 Antibody Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia HPLN1 Antibody Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America HPLN1 Antibody Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America HPLN1 Antibody Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa HPLN1 Antibody Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa HPLN1 Antibody Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Scientific Corporate Summary
Table 31. Thermo Fisher Scientific HPLN1 Antibody Product Offerings
Table 32. Thermo Fisher Scientific HPLN1 Antibody Revenue (US$, Mn), (2017-2022)
Table 33. R&D Systems Corporate Summary
Table 34. R&D Systems HPLN1 Antibody Product Offerings
Table 35. R&D Systems HPLN1 Antibody Revenue (US$, Mn), (2017-2022)
Table 36. Novus Biologicals Corporate Summary
Table 37. Novus Biologicals HPLN1 Antibody Product Offerings
Table 38. Novus Biologicals HPLN1 Antibody Revenue (US$, Mn), (2017-2022)
Table 39. Abcam Corporate Summary
Table 40. Abcam HPLN1 Antibody Product Offerings
Table 41. Abcam HPLN1 Antibody Revenue (US$, Mn), (2017-2022)
Table 42. Lifespan Biosciences Corporate Summary
Table 43. Lifespan Biosciences HPLN1 Antibody Product Offerings
Table 44. Lifespan Biosciences HPLN1 Antibody Revenue (US$, Mn), (2017-2022)
Table 45. Boster Bio Corporate Summary
Table 46. Boster Bio HPLN1 Antibody Product Offerings
Table 47. Boster Bio HPLN1 Antibody Revenue (US$, Mn), (2017-2022)
Table 48. Santa Cruz Biotechnology Corporate Summary
Table 49. Santa Cruz Biotechnology HPLN1 Antibody Product Offerings
Table 50. Santa Cruz Biotechnology HPLN1 Antibody Revenue (US$, Mn), (2017-2022)
Table 51. RayBiotech Corporate Summary
Table 52. RayBiotech HPLN1 Antibody Product Offerings
Table 53. RayBiotech HPLN1 Antibody Revenue (US$, Mn), (2017-2022)
Table 54. Abbexa Ltd Corporate Summary
Table 55. Abbexa Ltd HPLN1 Antibody Product Offerings
Table 56. Abbexa Ltd HPLN1 Antibody Revenue (US$, Mn), (2017-2022)
Table 57. Genetex Corporate Summary
Table 58. Genetex HPLN1 Antibody Product Offerings
Table 59. Genetex HPLN1 Antibody Revenue (US$, Mn), (2017-2022)
Table 60. Biobyt Corporate Summary
Table 61. Biobyt HPLN1 Antibody Product Offerings
Table 62. Biobyt HPLN1 Antibody Revenue (US$, Mn), (2017-2022)
Table 63. Aviva Systems Biology Corporate Summary
Table 64. Aviva Systems Biology HPLN1 Antibody Product Offerings
Table 65. Aviva Systems Biology HPLN1 Antibody Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. HPLN1 Antibody Segment by Type in 2021
Figure 2. HPLN1 Antibody Segment by Application in 2021
Figure 3. Global HPLN1 Antibody Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global HPLN1 Antibody Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global HPLN1 Antibody Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by HPLN1 Antibody Revenue in 2021
Figure 8. By Type - Global HPLN1 Antibody Revenue Market Share, 2017-2028
Figure 9. By Application - Global HPLN1 Antibody Revenue Market Share, 2017-2028
Figure 10. By Region - Global HPLN1 Antibody Revenue Market Share, 2017-2028
Figure 11. By Country - North America HPLN1 Antibody Revenue Market Share, 2017-2028
Figure 12. US HPLN1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 13. Canada HPLN1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico HPLN1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe HPLN1 Antibody Revenue Market Share, 2017-2028
Figure 16. Germany HPLN1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 17. France HPLN1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. HPLN1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 19. Italy HPLN1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 20. Russia HPLN1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries HPLN1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux HPLN1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia HPLN1 Antibody Revenue Market Share, 2017-2028
Figure 24. China HPLN1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 25. Japan HPLN1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea HPLN1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia HPLN1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 28. India HPLN1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America HPLN1 Antibody Revenue Market Share, 2017-2028
Figure 30. Brazil HPLN1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina HPLN1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa HPLN1 Antibody Revenue Market Share, 2017-2028
Figure 33. Turkey HPLN1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 34. Israel HPLN1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia HPLN1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 36. UAE HPLN1 Antibody Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Scientific HPLN1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. R&D Systems HPLN1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novus Biologicals HPLN1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Abcam HPLN1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Lifespan Biosciences HPLN1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Boster Bio HPLN1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Santa Cruz Biotechnology HPLN1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. RayBiotech HPLN1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Abbexa Ltd HPLN1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Genetex HPLN1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Biobyt HPLN1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Aviva Systems Biology HPLN1 Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)